World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary …
…, S Murali, RP Frantz, D McGlothlin, EM Horn… - The Journal of heart and …, 2012 - Elsevier
Pulmonary hypertension associated with left heart disease is the most common form of
pulmonary hypertension encountered in clinical practice today. Although frequently a target of …
pulmonary hypertension encountered in clinical practice today. Although frequently a target of …
Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association
Pulmonary hypertension, defined as an elevation in blood pressure in the pulmonary arteries,
is associated with an increased risk of death. The prevalence of pulmonary hypertension …
is associated with an increased risk of death. The prevalence of pulmonary hypertension …
[HTML][HTML] Clinical characteristics of Covid-19 in New York city
…, E Reshetnyak, N Hupert, EM Horn… - … England Journal of …, 2020 - Mass Medical Soc
Covid-19 in New York City In this series of 393 consecutive patients admitted with Covid-19
to two New York City hospitals from March 3 to March 27, a third of patients received …
to two New York City hospitals from March 3 to March 27, a third of patients received …
Suprapontine control of respiration
EM Horn, TG Waldrop - Respiration physiology, 1998 - Elsevier
Despite focus on brainstem areas in central respiratory control, regions rostral to the medulla
and pons are now recognized as being important in modulating respiratory outflow during …
and pons are now recognized as being important in modulating respiratory outflow during …
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
…, A Boonstra, LJ Rubin, EM Horn… - European …, 2004 - Eur Respiratory Soc
The efficacy and safety of combining bosentan, an orally active dual endothelin receptor
antagonist and epoprostenol, a continuously infused prostaglandin, in the treatment of …
antagonist and epoprostenol, a continuously infused prostaglandin, in the treatment of …
Sitaxsentan therapy for pulmonary arterial hypertension
RJ Barst, D Langleben, A Frost, EM Horn… - American journal of …, 2004 - atsjournals.org
Sitaxsentan may benefit patients with pulmonary arterial hypertension by blocking the
vasoconstrictor effects of endothelin-A while maintaining the vasodilator/clearance functions of …
vasoconstrictor effects of endothelin-A while maintaining the vasodilator/clearance functions of …
[BOOK][B] Building blocks
SR Sandall, IS Schwartz, GE Joseph, EM Horn… - 2008 - brookespublishing.com
… Horn is a professor and investigator at the University of Kansas (KU). She has worked in
early care and education, in the early childhood special education (ECSE) community, and in …
early care and education, in the early childhood special education (ECSE) community, and in …
[PDF][PDF] Clinical risk factors for portopulmonary hypertension
…, RL Benza, DB Badesch, DB Taichman, EM Horn… - …, 2008 - Wiley Online Library
Portopulmonary hypertension affects up to 6% of patients with advanced liver disease, but
the predictors and biologic mechanism for the development of this complication are unknown. …
the predictors and biologic mechanism for the development of this complication are unknown. …
New predictors of outcome in idiopathic pulmonary arterial hypertension
SM Kawut, EM Horn, KK Berekashvili… - The American journal of …, 2005 - Elsevier
Idiopathic pulmonary arterial hypertension (PAH) is a rare disease with a poor prognosis.
New therapies have improved the outcome of this condition; accordingly, the factors that …
New therapies have improved the outcome of this condition; accordingly, the factors that …
A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia
G Terheggen, EM Horn, M Vieth, H Gabbert, M Enderle… - Gut, 2017 - gut.bmj.com
Background For endoscopic resection of early GI neoplasia, endoscopic submucosal
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …